Full Text View
Tabular View
No Study Results Posted
Related Studies
Balance in Children With Cochlear Implants
This study is enrolling participants by invitation only.
Study NCT00642343   Information provided by University of Oklahoma
First Received: March 19, 2008   Last Updated: June 26, 2009   History of Changes

March 19, 2008
June 26, 2009
March 2008
February 2012   (final data collection date for primary outcome measure)
The specific aim will be to compare the balance of children with cochlear implants to profoundly deaf children using the BOT2. [ Time Frame: no earlier than 2 weeks following activation of implants ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00642343 on ClinicalTrials.gov Archive Site
To evaluate the differences in balance function between children with bilateral cochlear implants compared to children with unilateral cochlear using implants the BOT2. [ Time Frame: no earlier than 2 weeks after implant activation ] [ Designated as safety issue: Yes ]
Same as current
 
Balance in Children With Cochlear Implants
Balance in Children With Cochlear Implants

The purpose is to test the balance of children with unilateral,bilateral cochlear implants and patients having unilateral implants before,bilateral implants after surgery,using the Bruininks-Oseretsky Test 2nd ed. to find out if the cochlear implants have an effect.

Hearing impairment has a significant impact on individual quality of life and stresses community resources. In the last two decades cochlear implantation has developed into the new standard of care for severe to profound haring loss. Recent studies have shown bilateral implantation improves sound localization and understanding of speech in noise. For children, this is seen as a significant benefit. As we begin to offer bilateral cochlear implants to a growing number of children it would be in our patient's best interest to evaluate whether or not this may cause balance impairment. We will evaluate the balance scores of children with bilateral cochlear implants, and compare their results to unilaterally implanted children and a hearing impaired population, with the Bruininks-Oseretsky Test 2nd ed (BOT2). In addition we will take a small group of unilaterally implanted patients and test them before and after a contralateral cochlear implant as a prospective study group.

Phase 0
Interventional
Treatment, Open Label, Parallel Assignment, Safety Study
Severe, Profound Deafness
  • Behavioral: Evaluation of motor proficiency skills.
  • Behavioral: Evaluation of motor proficiency
  • Behavioral: Evaluation of motor proficiency.
  • Placebo Comparator: Children with severe to profound deafness that have not received any intervention.
  • Active Comparator: Children with an unilateral cochlear implant.
  • Active Comparator: Children with bilateral cochlear implants.
  • Active Comparator: Children who receive their second implant during the duration of the study.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Enrolling by invitation
150
February 2012
February 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Children with cochlear implant(s) activated for at least two weeks before participation.
  • Children with severe to profound deafness that have not received intervention.

Exclusion Criteria:

  • Children with mental retardation, associated physical handicaps, or chronic sedative use prohibiting completion of the balance tests.
Both
4 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00642343
Wayne Berryhill, M.D., University of Oklahoma Health Sciences Center
BALANCE W/COCHLEAR_BERRYHILL
University of Oklahoma
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Principal Investigator: Wayne Berryhill, MD University of Oklahoma
University of Oklahoma
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP